Clinical Trial Details
| Trial ID: | L0909 |
| Source ID: | NCT00646035 |
| Associated Drug: | Paricalcitol Capsules |
| Title: | A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | End Stage Renal Disease |
| Interventions: | DRUG: paricalcitol capsules |
| Outcome Measures: | Primary: The achievement of two consecutive greater than or equal to 30% decreases from baseline iPTH levels., 12 weeks|The incidence of clinically meaningful hypercalcemia and elevated Ca x P., 12 weeks | |
| Sponsor/Collaborators: | Sponsor: Abbott |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE3 |
| Enrollment: | 75 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT |
| Start Date: | 2002-01 |
| Completion Date: | |
| Results First Posted: | |
| Last Update Posted: | 2008-03-28 |
| Locations: | Los Angeles, California, 90095, United States|Denver, Colorado, 80230, United States|Washington, District of Columbia, 20007, United States|Fort Myers, Florida, 33919, United States|Tampa, Florida, 33603, United States|Savannah, Georgia, 31405, United States|Evanston, Illinois, 60201, United States|Maywood, Illinois, 60153, United States|Indianapolis, Indiana, 46202, United States|New Orleans, Louisiana, 70112, United States|St. Louis, Missouri, 63110, United States|Las Vegas, Nevada, 89102, United States|Mineola, New York, 11501, United States|Cincinnati, Ohio, 45206, United States|Cincinnati, Ohio, 45220, United States|Cleveland, Ohio, 44195, United States|Portland, Oregon, 97210, United States|Charleston, South Carolina, 29425, United States|Memphis, Tennessee, 38105, United States|Nashville, Tennessee, 37205, United States|Houston, Texas, 77030, United States|Lubbock, Texas, 79430, United States|Krakow, 30-501, Poland|Krakow, Poland |
| URL: | https://clinicaltrials.gov/show/NCT00646035 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|